The efficacy of boosters against COVID-19 is likely to decline over the next few months and people may need another shot in the fall of 2022, Moderna Inc Chief Executive Officer Stephane Bancel said at a Goldman Sachs-organized health-care conference on Thursday.
Bancel said the company is working on a vaccine candidate tailored to the Omicron variant of the coronavirus, but is unlikely to be available in the next two months.
![For news impacting Canada and around the world, sign up for breaking news alerts delivered directly to you when they happen.](https://globalnews.ca/wp-content/themes/shaw-globalnews/images/skyline/national.jpg)
Get breaking National news
“I still believe we’re going to need boosters in the fall of ’22 and forward,” Bancel said.
His comments on needing a fourth shot come on the back of Israeli Prime Minister Naftali Bennett citing a study on Tuesday that a fourth dose of COVID-19 vaccine boosts antibodies five-fold a week after the shot is administered.
Moderna, which benefits by repeat inoculations, during its third quarter earnings results said commercial booster market sales could be up to $2 billion in the United States in 2022.
Comments